Why PCVX? Vaxcyte, Inc. Analysis, Price & AI Insights | Whystock
PCVX
$58.49+1.56 (+2.74%)
Market ClosedLast close May 4
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.